With increasingly less face-to-face patient interaction, manufacturers need to rethink traditional solutions in order to alleviate access barriers.
Despite best efforts, prescription rates continue to drop as newly launched products experience increased patient drop-off; and companies are struggling to support patient acquisition, retention and conversion.
In a new 60-minute virtual panel, PharmaVOICE Co-Founder and Editor Taren Grom will interview EVERSANA’s Maria Kirsch and other industry leaders to discuss how changing market dynamics are creating a need for next gen patient services.
During this event, you’ll learn how to:
- Leverage innovative technology, such as advanced analytics and machine learning, to overcome access barriers;
- Personalize patient and HCP engagement; and
- Maximize outcomes throughout the patient journey and demonstrate therapeutic success.
EVERSANA employs a team of over 6000 professionals across 40+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…